Effector Therapeutics Stock Price History
EFTR Stock | USD 1.85 0.09 4.64% |
If you're considering investing in Effector Stock, it is important to understand the factors that can impact its price. As of today, the current price of Effector Therapeutics stands at 1.85, as last reported on the 24th of April, with the highest price reaching 2.00 and the lowest price hitting 1.78 during the day. Effector Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0627, which denotes the company had a -0.0627% return per unit of risk over the last 3 months. Effector Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Effector Therapeutics' Variance of 150.82, standard deviation of 12.28, and Mean Deviation of 6.86 to check the risk estimate we provide.
At this time, Effector Therapeutics' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 04/24/2024, Sale Purchase Of Stock is likely to grow to about 67.6 K, while Common Stock Shares Outstanding is likely to drop slightly above 1.5 M. . As of 04/24/2024, Price To Sales Ratio is likely to drop to 4.24. In addition to that, Price Earnings Ratio is likely to grow to -0.68. Effector Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Effector |
Sharpe Ratio = -0.0627
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | EFTR |
Estimated Market Risk
12.52 actual daily | 96 96% of assets are less volatile |
Expected Return
-0.79 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Effector Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Effector Therapeutics by adding Effector Therapeutics to a well-diversified portfolio.
Price Book 13.3845 | Enterprise Value Ebitda (0.30) | Price Sales 69.6486 | Shares Float 3.4 M | Wall Street Target Price 11 |
Effector Therapeutics Stock Price History Chart
There are several ways to analyze Effector Stock price data. The simplest method is using a basic Effector candlestick price chart, which shows Effector Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 4, 2024 | 16.95 |
Lowest Price | April 19, 2024 | 1.7 |
Effector Therapeutics April 24, 2024 Stock Price Synopsis
Various analyses of Effector Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Effector Stock. It can be used to describe the percentage change in the price of Effector Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Effector Stock.Effector Therapeutics Price Daily Balance Of Power | (0.41) | |
Effector Therapeutics Price Rate Of Daily Change | 0.95 | |
Effector Therapeutics Price Action Indicator | (0.08) |
Effector Therapeutics April 24, 2024 Stock Price Analysis
Effector Stock Price History Data
The price series of Effector Therapeutics for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 15.25 with a coefficient of variation of 44.95. Under current investment horizon, the daily prices are spread out with arithmetic mean of 10.08. The median price for the last 90 days is 11.06. The company completed 1:25 stock split on 12th of January 2024.Open | High | Low | Close | Volume | ||
04/24/2024 | 1.94 | 2.00 | 1.78 | 1.85 | ||
04/23/2024 | 1.80 | 2.00 | 1.78 | 1.94 | 149,613 | |
04/22/2024 | 1.67 | 1.87 | 1.63 | 1.78 | 177,227 | |
04/19/2024 | 1.80 | 1.80 | 1.60 | 1.70 | 197,073 | |
04/18/2024 | 1.91 | 1.91 | 1.75 | 1.78 | 146,195 | |
04/17/2024 | 2.01 | 2.05 | 1.81 | 1.89 | 136,014 | |
04/16/2024 | 1.89 | 2.03 | 1.89 | 1.99 | 234,386 | |
04/15/2024 | 2.12 | 2.12 | 1.83 | 1.93 | 412,408 | |
04/12/2024 | 2.27 | 2.27 | 2.03 | 2.08 | 294,306 | |
04/11/2024 | 2.34 | 2.37 | 2.17 | 2.24 | 347,235 | |
04/10/2024 | 2.31 | 2.39 | 2.24 | 2.36 | 255,813 | |
04/09/2024 | 2.17 | 2.46 | 2.14 | 2.31 | 818,706 | |
04/08/2024 | 2.44 | 2.44 | 2.10 | 2.13 | 1,336,570 | |
04/05/2024 | 2.89 | 2.95 | 2.49 | 2.51 | 2,398,972 | |
04/04/2024 | 3.60 | 4.10 | 2.76 | 2.96 | 8,725,275 | |
04/03/2024 | 15.26 | 16.88 | 15.07 | 16.47 | 246,976 | |
04/02/2024 | 15.50 | 16.12 | 14.03 | 15.41 | 126,640 | |
04/01/2024 | 14.37 | 16.55 | 13.96 | 15.67 | 350,293 | |
03/28/2024 | 13.25 | 14.72 | 13.25 | 14.39 | 351,712 | |
03/27/2024 | 12.82 | 13.72 | 12.38 | 13.45 | 164,382 | |
03/26/2024 | 12.29 | 13.49 | 11.10 | 12.91 | 487,638 | |
03/25/2024 | 12.97 | 14.28 | 12.55 | 13.76 | 325,055 | |
03/22/2024 | 12.58 | 12.91 | 12.00 | 12.33 | 86,368 | |
03/21/2024 | 12.88 | 13.15 | 11.69 | 12.95 | 143,724 | |
03/20/2024 | 12.50 | 12.85 | 12.05 | 12.85 | 58,640 | |
03/19/2024 | 11.96 | 12.95 | 11.71 | 12.27 | 79,745 | |
03/18/2024 | 11.30 | 13.15 | 11.30 | 11.87 | 156,695 | |
03/15/2024 | 10.88 | 11.34 | 10.81 | 11.06 | 114,477 | |
03/14/2024 | 10.76 | 11.27 | 10.75 | 10.85 | 75,530 | |
03/13/2024 | 11.11 | 11.55 | 10.50 | 10.88 | 127,529 | |
03/12/2024 | 10.85 | 11.83 | 10.51 | 11.15 | 158,752 | |
03/11/2024 | 13.25 | 13.62 | 10.85 | 11.12 | 414,055 | |
03/08/2024 | 14.62 | 15.25 | 12.36 | 13.16 | 465,816 | |
03/07/2024 | 16.56 | 16.74 | 14.93 | 14.99 | 159,679 | |
03/06/2024 | 16.00 | 16.92 | 15.38 | 16.68 | 172,756 | |
03/05/2024 | 17.19 | 17.22 | 15.11 | 15.57 | 264,664 | |
03/04/2024 | 16.99 | 17.75 | 16.01 | 16.95 | 310,275 | |
03/01/2024 | 14.40 | 16.67 | 14.05 | 16.20 | 291,876 | |
02/29/2024 | 13.59 | 14.44 | 12.81 | 14.44 | 162,658 | |
02/28/2024 | 13.50 | 15.00 | 13.44 | 13.59 | 343,880 | |
02/27/2024 | 11.62 | 13.54 | 11.62 | 13.14 | 360,402 | |
02/26/2024 | 11.07 | 11.92 | 11.03 | 11.62 | 100,284 | |
02/23/2024 | 11.17 | 11.27 | 10.74 | 11.12 | 78,212 | |
02/22/2024 | 10.90 | 11.29 | 10.50 | 11.04 | 77,781 | |
02/21/2024 | 11.11 | 11.34 | 10.42 | 10.84 | 68,064 | |
02/20/2024 | 11.50 | 11.93 | 10.60 | 10.99 | 102,103 | |
02/16/2024 | 11.59 | 11.90 | 11.25 | 11.32 | 61,298 | |
02/15/2024 | 12.12 | 12.64 | 11.29 | 11.66 | 136,925 | |
02/14/2024 | 11.00 | 12.27 | 10.45 | 12.19 | 204,085 | |
02/13/2024 | 10.80 | 11.43 | 10.62 | 10.99 | 60,731 | |
02/12/2024 | 10.60 | 11.09 | 10.40 | 10.77 | 86,758 | |
02/09/2024 | 10.44 | 11.00 | 10.27 | 10.70 | 44,164 | |
02/08/2024 | 10.09 | 10.65 | 9.78 | 10.51 | 45,940 | |
02/07/2024 | 10.37 | 10.37 | 9.78 | 9.95 | 36,908 | |
02/06/2024 | 10.16 | 10.40 | 10.08 | 10.34 | 57,287 | |
02/05/2024 | 10.57 | 10.82 | 9.80 | 10.11 | 50,297 | |
02/02/2024 | 11.03 | 11.18 | 10.28 | 10.56 | 111,220 | |
02/01/2024 | 11.49 | 11.87 | 10.95 | 11.19 | 107,466 | |
01/31/2024 | 10.79 | 11.60 | 10.79 | 11.47 | 55,602 | |
01/30/2024 | 11.44 | 11.95 | 10.49 | 11.32 | 118,944 | |
01/29/2024 | 10.43 | 12.00 | 10.43 | 11.70 | 187,635 |
About Effector Therapeutics Stock history
Effector Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Effector is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Effector Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Effector Therapeutics stock prices may prove useful in developing a viable investing in Effector Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.2 M | 1.5 M | |
Net Loss | -20.4 M | -19.4 M |
Effector Therapeutics Stock Technical Analysis
Effector Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
Effector Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Effector Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Effector Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Effector to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (1.44) | |||
Total Risk Alpha | (2.67) | |||
Treynor Ratio | (0.19) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Effector Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Effector Stock, please use our How to Invest in Effector Therapeutics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Effector Stock analysis
When running Effector Therapeutics' price analysis, check to measure Effector Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Effector Therapeutics is operating at the current time. Most of Effector Therapeutics' value examination focuses on studying past and present price action to predict the probability of Effector Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Effector Therapeutics' price. Additionally, you may evaluate how the addition of Effector Therapeutics to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Effector Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Effector Therapeutics. If investors know Effector will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Effector Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.37) | Revenue Per Share 0.349 | Quarterly Revenue Growth 1.17 | Return On Assets (0.85) | Return On Equity (9.47) |
The market value of Effector Therapeutics is measured differently than its book value, which is the value of Effector that is recorded on the company's balance sheet. Investors also form their own opinion of Effector Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Effector Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Effector Therapeutics' market value can be influenced by many factors that don't directly affect Effector Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Effector Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Effector Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Effector Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.